Join Growin Stock Community!
Back to PBYI.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

operation-income-chart

PBYI Operation Income

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

Puma biotechnology, inc. (PBYI) 2025Q4 financial report shows operating profit of 17.11M USD, with a YoY growth rate of 27.99%, clearly higher than last year, reflecting solid business operations and good profit flexibility. It is recommended to also monitor the structure of operating profit, recent revenue, and gross margin, and compare with peers, using Growin AI Value Analysis to confirm whether the growth is supported by fundamentals. If the company can maintain this steady growth, it is commendable.